FDA
Lamivudine; Tenofovir Disoproxil Fumarate
The FDA lists this product in 3 strengths and forms.
Composition
- Active ingredients
- LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG · TabletThis page
- LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG · TabletNDA202529-001 · Tentative approval
- LAMIVUDINE 300MG; TENOFOVIR DISOPROXIL FUMARATE 300MG · TabletNDA203283-001 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA200623.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.